8.8916

3.10% -0.1484

Wave Life Sciences Ltd (WVE)

Overview News Price History Option Chain Financials Why WVE Down? Discussions Forecast

Wave Life Sciences Ltd stock is traded at $8.8916, with a volume of 656.59K. It is down -3.10% in the last 24 hours and up +22.52% over the past month. WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Previous Close:

$9.04

Open:

$8.9

24h Volume:

656.59K

Relative Volume:

0.27

Market Cap:

$1.40B

Revenue:

$93.95M

Net Income/Loss:

$-129.87M

P/E Ratio:

-9.8796

EPS:

-0.9

Net Cash Flow:

$-202.88M

1W Performance:

+14.96%

1M Performance:

+22.52%

6M Performance:

+8.15%

1Y Performance:

-36.66%

1-Day Range:

$8.76

$9.13

1-Week Range:

$7.34

$9.75

52-Week Range:

$5.28

$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Name

Wave Life Sciences Ltd

Sector

Healthcare (1136)

Industry

Biotechnology (635)

Phone

617-949-2900

Address

7 STRAITS VIEW, SINGAPORE

Employee

288

Twitter

@WAVELifeSci

Next Earnings Date

2025-03-04

Latest SEC Filings

WVE's Discussions on Twitter

Compare WVE with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WVE Wave Life Sciences Ltd	8.78	1.44B	93.95M	-129.87M	-202.88M	-0.90
VRTX Vertex Pharmaceuticals Inc	423.38	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	636.02	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	442.39	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	824.56	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	181.97	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Initiated	Wells Fargo	Overweight
Aug-04-25	Initiated	Canaccord Genuity	Buy
Jul-28-25	Initiated	Oppenheimer	Outperform
Jul-16-25	Initiated	Citigroup	Buy
Jun-11-25	Resumed	Raymond James	Outperform
Apr-29-25	Initiated	Cantor Fitzgerald	Overweight
Apr-08-25	Initiated	Wedbush	Outperform
Feb-25-25	Initiated	Jefferies	Buy
Oct-16-24	Upgrade	Raymond James	Outperform → Strong Buy
Sep-27-24	Resumed	JP Morgan	Overweight
Sep-19-24	Initiated	B. Riley Securities	Buy
Sep-09-24	Initiated	JP Morgan	Overweight
May-15-24	Initiated	Wells Fargo	Overweight
Dec-19-23	Upgrade	Leerink Partners	Market Perform → Outperform
Jul-05-23	Initiated	Raymond James	Outperform
May-24-23	Downgrade	Jefferies	Buy → Hold
Dec-15-20	Resumed	H.C. Wainwright	Buy
Oct-23-20	Initiated	RBC Capital Mkts	Sector Perform
Dec-31-19	Downgrade	SVB Leerink	Outperform → Mkt Perform
Nov-01-19	Initiated	Guggenheim	Buy
Jul-15-19	Initiated	Cowen	Market Perform
Apr-17-19	Reiterated	H.C. Wainwright	Buy
Aug-07-18	Initiated	Stifel	Buy
Jul-23-18	Initiated	H.C. Wainwright	Buy
Mar-19-18	Reiterated	Mizuho	Buy
Feb-15-17	Initiated	H.C. Wainwright	Buy
Nov-10-16	Resumed	Leerink Partners	Outperform
Dec-07-15	Initiated	JMP Securities	Mkt Outperform
Dec-07-15	Initiated	Jefferies	Buy
Dec-07-15	Initiated	Leerink Partners	Outperform
Dec-07-15	Initiated	Sun Trust Rbsn Humphrey	Buy

View All

Wave Life Sciences Ltd Stock (WVE) Latest News

07:38 AM

How Wave Life Sciences Ltd. stock compares to market leadersJuly 2025 Analyst Calls & Advanced Technical Analysis Signals - newser.com

07:38 AM

05:02 AM

Is Wave Life Sciences Ltd. stock entering bullish territoryJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com

05:02 AM

04:27 AM

Can Wave Life Sciences Ltd. rally from current levelsJuly 2025 Trends & Weekly Return Optimization Alerts - newser.com

04:27 AM

03:49 AM

Will Wave Life Sciences Ltd. (1U5) stock hit analyst forecastsJuly 2025 Selloffs & Low Drawdown Investment Strategies - newser.com

03:49 AM

03:20 AM

Candlestick signals on Wave Life Sciences Ltd. stock todayJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com

03:20 AM

01:51 AM

Heatmap analysis for Wave Life Sciences Ltd. and competitorsJuly 2025 Price Swings & Weekly Hot Stock Watchlists - newser.com

01:51 AM

01:30 AM

Can Wave Life Sciences Ltd. (1U5) stock withstand sector downturnsLong Setup & Technical Pattern Alert System - newser.com

01:30 AM

Nov 02, 2025

Can Wave Life Sciences Ltd. stock deliver sustainable ROE2025 Biggest Moves & Verified Entry Point Signals - newser.com

Nov 02, 2025

Can Wave Life Sciences Ltd. (1U5) stock sustain revenue momentum2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com

Nov 02, 2025

Wave Life Sciences Reports Breakthrough in Obesity Treatment - StocksToTrade

Nov 02, 2025

Why Wave Life Sciences Ltd. stock is favored by pension fundsPortfolio Update Summary & Weekly High Return Forecasts - newser.com

Nov 02, 2025

What insider trading reveals about Wave Life Sciences Ltd. stockWall Street Watch & Low Risk High Reward Ideas - newser.com

Nov 02, 2025

Nov 01, 2025

Wave Life Sciences Hits Day High with 8.83% Surge in Stock Price - Markets Mojo

Nov 01, 2025

Wave Life Sciences Ltd. (NASDAQ:WVE) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected - simplywall.st

Nov 01, 2025

Oct 31, 2025

Wave, Ibio activin E action in obesity early but solid - BioWorld MedTech

Oct 31, 2025

Can Wave Life Sciences Ltd. recover in the next quarter2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com

Oct 31, 2025

Is Wave Life Sciences Ltd. stock positioned for digital transformationTrade Exit Report & Real-Time Volume Spike Alerts - newser.com

Oct 31, 2025

Visual analytics tools that track Wave Life Sciences Ltd. performanceWeekly Trend Summary & Technical Entry and Exit Alerts - newser.com

Oct 31, 2025

Can Wave Life Sciences Ltd. (1U5) stock expand revenue streamsJuly 2025 Sector Moves & Fast Exit Strategy with Risk Control - newser.com

Oct 31, 2025

Wave Life Sciences’ obesity siRNA shows “once or twice-yearly” potential - Clinical Trials Arena

Oct 31, 2025

Will Wave Life Sciences Ltd. (1U5) stock top growth indexes2025 Analyst Calls & High Return Stock Watch Alerts - newser.com

Oct 31, 2025

Oct 30, 2025

WAVE Life Sciences (NASDAQ:WVE) Sees Large Volume IncreaseHere's Why - MarketBeat

Oct 30, 2025

Emerald Advisers LLC Has $21.17 Million Holdings in WAVE Life Sciences Ltd. $WVE - MarketBeat

Oct 30, 2025

A Fresh Look at Wave Life Sciences (WVE) Valuation After Recent Share Price Rally - simplywall.st

Oct 30, 2025

Wave Life Sciences’ WVE-007 Study: A New Frontier in Obesity Treatment - MSN

Oct 30, 2025

WVE files amended 8-K; corrected Exhibit 99.1, Research Day recap - Stock Titan

Oct 30, 2025

Wave Life Sciences (WVE) Soars 8.8%: Is Further Upside Left in the Stock? - Nasdaq

Oct 30, 2025

Oct 29, 2025

Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire

Oct 29, 2025

Wave Life Sciences (NASDAQ: WVE) posts 85% Activin E drop, 6‑mo durable in INLIGHT - Stock Titan

Oct 29, 2025

Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day - GlobeNewswire Inc.

Oct 29, 2025